Turn Therapeutics (TTRX) Research & Development (2024 - 2026)
Turn Therapeutics' quarterly Research & Development came in at $109434.0 in Q1 2026, up 1081.92% year-on-year from $9259.0 in Q1 2025, and up 213.26% quarter-over-quarter from $34934.0 in Q4 2025.
Turn Therapeutics has reported Research & Development for 3 years, with the latest figure at $109434.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 1081.92% year-over-year to $109434.0; the trailing twelve-month figure through Mar 2026 stood at $312326.0 (changed N/A YoY), and the FY2025 full-year result was $265570.0, up 7.97% from the prior year.
- Research & Development for Q1 2026 stood at $109434.0, up from $34934.0 in the prior quarter.
- The five-year high for Research & Development was $158699.0 in Q3 2025, with the low at $9259.0 in Q1 2025.
- Average Research & Development over 3 years is $79229.0, with a median of $72184.0 recorded in 2025.
- Year-over-year, Research & Development advanced 3.53% in 2025 and jumped 1081.92% in 2026.
- Tracing TTRX's Research & Development over 3 years: stood at $9766.0 in 2024, then soared by 257.71% to $34934.0 in 2025, then jumped by 213.26% to $109434.0 in 2026.
- The last three Research & Development figures came in at $109434.0 (Q1 2026), $34934.0 (Q4 2025), and $158699.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | 109,434.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,434.00 |
| Dec 31, 2025 | 34,934.00 |
| Sep 30, 2025 | 158,699.00 |
| Mar 31, 2025 | 9,259.00 |
| Dec 31, 2024 | 9,766.00 |
| Sep 30, 2024 | 153,282.00 |